MENU
AVTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Avalo Therapeutics (AVTX) Ownership - Who owns Avalo Therapeutics?
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation... Show more
Industry: #Pharmaceuticals Other
Profile
Industry
Pharmaceuticals Other
Address
540 Gaither Road
Phone
+1 410 522-8707
Employees
19
Web
https://www.avalotx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
51.97M
P/E Ratio
0.04
Total Cash
125.05M
Projected Growth
N/A
Total Debt
801K
Revenue
441K
Risk (Beta)
-0.45
Dividend Yield
N/A
Total Cash/Share
11.55
Total Debt/Equity
N/A
Revenue/Share
0.04 USD as % of share price
Fundamentals
AVTX
Capitalization
52M
P/E Ratio
0.04
Risk (Beta)
-0.45
Dividend Yield
N/A
Total Cash
125M
Total Cash/Share
11.55
Total Debt
801K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.04%
Revenue
441K
ROE
N/A
Book Value
123M
P/B Ratio
0.42
Cash Flow
N/A
Earnings
131.95
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
11K
Current Ratio
22.61
Current Revenue Per Employee
10105.26
Dividends Per Share - Security
N/A
EBITDA
-50.14M
Float
N/A
Float - Current
N/A
Gross Income Margin
54.69
Revenue To Assets
55.68
Shares Held By Institutions
67.1M
Shares Outstanding - Current
10.8M
Total Liabilities
15.9M
Total Volume MTD
N/A
Value
-1
Gain YTD
-35.666
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical stage biopharmaceutical company
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
540 Gaither Road
Phone
+1 410 522-8707
Employees
19
Web
https://www.avalotx.com